AliHussainAl-KhafajiMD

Internal Medicine • Pittsburgh, PA

Critical Care Medicine

Professor, Critical Care Medicine and Surgery, University of Pittsburgh School of Medicine

Join to view full profile

Dr. Al-Khafaji is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Al-Khafaji's full profile

Already have an account?

Office
200 Lothrop St
Pittsburgh, PA 15213
Phone+1 412-647-3136

Fax+1 412-647-4486

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Critical Care Medicine (Internal Medicine), 1999 - 2001
UPMC Medical Education/MercyResidency, Internal Medicine, 1996 - 1999
University of Al-Mustansiriyah College of MedicineClass of 1993

Certifications & Licensure

NH State Medical License 1999 - Present
PA State Medical License 1997 - 2026
FL State Medical License 2019 - 2023
ND State Medical License 2001 - 2002
American Board of Internal Medicine Critical Care Medicine

Clinical Trials

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Completed
Phase 3

Publications & Presentations

PubMed

Challenges and Opportunities in the Adoption of p-TIPS for Acute Variceal Bleeding: Insights from a US Tertiary Center.
Stela Celaj, J Estevez, Paula Novelli, Philip Orons, Ali Al-Khafaji
Digestive Diseases and Sciences. 2025-01-01
1 citations
Risk Factors and Outcomes Associated With the Development of Persistent Acute Kidney Injury in Non-Renal Solid Organ Transplant Recipients: Systematic Review and Meta-...
Ivan E Saraiva, Natsumi Hamahata, Ankit Sakhuja, Xinlei Chen, John S Minturn
Clinical Transplantation. 2024-09-01
Expedited liver transplantation as first-line therapy for severe alcohol hepatitis: ELFSAH; deferring corticosteroids in the sickest subset of patients.
Nabeeha Mohy-Ud-Din, Fei-Pi Lin, Vikrant Rachakonda, Ali Al-Khafaji, Scott W Biggins
Clinical Transplantation. 2024-07-01

Press Mentions

Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion CriteriaNovember 29th, 2021